Injera (Eragrostis tef)-restricted diet’s role in the management of type 2 diabetes: A case study

Daba, Miheret, Abebe, Moges 1 and Hailemeskel, Bisrat 2, *

1 Department of Biological and Physical Sciences, Saint Augustine University, USA.
2 College of Pharmacy, Howard University, 2300 4th Street, NW., Washington, DC 20059
 
Research Article
International Journal of Scholarly Research in Biology and Pharmacy, 2024, 04(02), 046–050.
Article DOI: 10.56781/ijsrbp.2024.4.2.0224
Publication history: 
Received on 14 May 2024; revised on 22 June 2024; accepted on 25 June 2024
 
Abstract: 
Injera, a soft, fluffy bread made from Eragrostis tef, is a staple food in Ethiopian and Eritrean cuisine, consumed by over 90 percent of the population in those two countries, including those in diaspora. Despite being marketed as gluten-free, there has been a misconception regarding its impact on blood sugar levels. This case study investigates the efficacy of a diet restricted in injera consumption in reducing hemoglobin A1C (HbA1C) levels over a 90-day period. The intervention emphasizes limited intake of injera. Results indicate a significant reduction from the initial baseline HbA1C level of 7.5% to 5.3% by Day 90, This is a 30% decrease surpassing the recommended target for glycemic control in diabetics. Therefore, despite its gluten-free marketing, injera consumption can significantly impact blood sugar levels. This underscores the importance of understanding the dietary implications of staple foods like injera, especially for individuals managing diabetes.
 
Keywords: 
Injera; Eragrostis tef; Blood sugar levels; Hemoglobin A1C (HbA1C); Ethiopia; Eritrea
 
Full text article in PDF: